-
1
-
-
0033835996
-
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
-
Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K.et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919.
-
(2000)
Nat. Med.
, vol.6
, pp. 916-919
-
-
Bard, F.1
Cannon, C.2
Barbour, R.3
Burke, R.L.4
Games, D.5
Grajeda, H.6
Guido, T.7
Hu, K.8
Huang, J.9
Johnson-Wood, K.10
-
2
-
-
0037452779
-
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
-
Bard F., Barbour R., Cannon C., Carretto R., Fox M., Games D., Guido T., Hoenow K., Hu K., Johnson-Wood K.et al. Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci. USA. 100:2003;2023-2028.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 2023-2028
-
-
Bard, F.1
Barbour, R.2
Cannon, C.3
Carretto, R.4
Fox, M.5
Games, D.6
Guido, T.7
Hoenow, K.8
Hu, K.9
Johnson-Wood, K.10
-
3
-
-
0034700480
-
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
-
Chen G.Q., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979.
-
(2000)
Nature
, vol.408
, pp. 975-979
-
-
Chen, G.Q.1
Chen, K.S.2
Knox, J.3
Inglis, J.4
Bernard, A.5
Martin, S.J.6
Justice, A.7
McConlogue, L.8
Games, D.9
Freedman, S.B.10
Morris, R.G.11
-
4
-
-
0036828769
-
Alzheimer's disease: Treatments in discovery and development
-
Citron M. Alzheimer's disease. treatments in discovery and development Nat. Neurosci. 5:2002;1055-1057.
-
(2002)
Nat. Neurosci.
, vol.5
, pp. 1055-1057
-
-
Citron, M.1
-
5
-
-
0035902619
-
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
-
DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., Holtzman D.M. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 98:2001;8850-8855.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 8850-8855
-
-
DeMattos, R.B.1
Bales, K.R.2
Cummins, D.J.3
Dodart, J.C.4
Paul, S.M.5
Holtzman, D.M.6
-
6
-
-
0037155581
-
Brain to plasma amyloid-β efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease
-
DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-β efflux. a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science. 295:2002;2264-2267.
-
(2002)
Science
, vol.295
, pp. 2264-2267
-
-
DeMattos, R.B.1
Bales, K.R.2
Cummins, D.J.3
Paul, S.M.4
Holtzman, D.M.5
-
7
-
-
0036240395
-
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
-
Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., DeLong C.A., Wu S., Wu X., Holtzman D.M., Paul S.M. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nat. Neurosci. 5:2002;452-457.
-
(2002)
Nat. Neurosci.
, vol.5
, pp. 452-457
-
-
Dodart, J.C.1
Bales, K.R.2
Gannon, K.S.3
Greene, S.J.4
DeMattos, R.B.5
Mathis, C.6
DeLong, C.A.7
Wu, S.8
Wu, X.9
Holtzman, D.M.10
Paul, S.M.11
-
8
-
-
0036639707
-
Novel strategies provide the real test for the amyloid hypothesis of Alzheimer's disease
-
Dominguez D.I., De Strooper B. Novel strategies provide the real test for the amyloid hypothesis of Alzheimer's disease. Trends Pharmacol. Sci. 23:2002;324-330.
-
(2002)
Trends Pharmacol. Sci.
, vol.23
, pp. 324-330
-
-
Dominguez, D.I.1
De Strooper, B.2
-
9
-
-
0035103036
-
Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
-
Doody R.S., Geldmacher D.S., Gordon B., Perdomo C.A., Pratt R.D. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch. Neurol. 58:2001;427-433.
-
(2001)
Arch. Neurol.
, vol.58
, pp. 427-433
-
-
Doody, R.S.1
Geldmacher, D.S.2
Gordon, B.3
Perdomo, C.A.4
Pratt, R.D.5
-
10
-
-
0016823810
-
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
-
Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
-
(1975)
J. Psychiatr. Res.
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
11
-
-
0036860342
-
Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease
-
Gandy S. Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease. Neurobiol. Aging. 23:2002;1009-1016.
-
(2002)
Neurobiol. Aging
, vol.23
, pp. 1009-1016
-
-
Gandy, S.1
-
13
-
-
0031824782
-
Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
-
Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., Yankner B.A. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4:1998;827-831.
-
(1998)
Nat. Med.
, vol.4
, pp. 827-831
-
-
Geula, C.1
Wu, C.K.2
Saroff, D.3
Lorenzo, A.4
Yuan, M.5
Yankner, B.A.6
-
14
-
-
0034082560
-
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease
-
Giacobini E. Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14:2000;S3-S10.
-
(2000)
Alzheimer Dis. Assoc. Disord.
, vol.14
-
-
Giacobini, E.1
-
15
-
-
0037248301
-
Alzheimer disease therapy: Can the amyloid cascade be halted?
-
Golde T.E. Alzheimer disease therapy. can the amyloid cascade be halted? J. Clin. Invest. 111:2003;11-18.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 11-18
-
-
Golde, T.E.1
-
16
-
-
0035943436
-
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
-
Götz J., Chen F., vanDorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science. 293:2001;1491-1495.
-
(2001)
Science
, vol.293
, pp. 1491-1495
-
-
Götz, J.1
Chen, F.2
VanDorpe, J.3
Nitsch, R.M.4
-
17
-
-
0029789379
-
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
-
Growdon J.H., Locascio J.J., Corkin S., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 47:1996;444-448.
-
(1996)
Neurology
, vol.47
, pp. 444-448
-
-
Growdon, J.H.1
Locascio, J.J.2
Corkin, S.3
Gomez-Isla, T.4
Hyman, B.T.5
-
18
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease. progress and problems on the road to therapeutics Science. 297:2002;353-356.
-
(2002)
Science
, vol.297
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
19
-
-
0036853548
-
Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
-
Hock C., Konietzko U., Papassotiropoulos A., Wollmer A., Streffer J., von Rotz R.C., Davey G., Moritz E., Nitsch R.M. Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease. Nat. Med. 8:2002;1270-1275.
-
(2002)
Nat. Med.
, vol.8
, pp. 1270-1275
-
-
Hock, C.1
Konietzko, U.2
Papassotiropoulos, A.3
Wollmer, A.4
Streffer, J.5
Von Rotz, R.C.6
Davey, G.7
Moritz, E.8
Nitsch, R.M.9
-
20
-
-
0031914718
-
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes
-
Holcomb L., Gorson M.N., McGowan F., Yu X., Benkovic S., Janzen P., Wright K., Saad I., Mueller R., Morgan D.et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes. Nat. Med. 4:1998;97-100.
-
(1998)
Nat. Med.
, vol.4
, pp. 97-100
-
-
Holcomb, L.1
Gorson, M.N.2
McGowan, F.3
Yu, X.4
Benkovic, S.5
Janzen, P.6
Wright, K.7
Saad, I.8
Mueller, R.9
Morgan, D.10
-
21
-
-
0036376917
-
Disordered proteins in dementia
-
Ingelsson M., Hyman B.T. Disordered proteins in dementia. Ann. Med. 34:2002;259-271.
-
(2002)
Ann. Med.
, vol.34
, pp. 259-271
-
-
Ingelsson, M.1
Hyman, B.T.2
-
22
-
-
0034700471
-
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
-
Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J.et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
-
(2000)
Nature
, vol.408
, pp. 979-982
-
-
Janus, C.1
Pearson, J.2
McLaurin, J.3
Mathews, P.M.4
Jiang, Y.5
Schmidt, S.D.6
Chishti, M.A.7
Horne, P.8
Heslin, D.9
French, J.10
-
23
-
-
0028114429
-
The Clinician Interview-Based Impression (CIBI): A clinician's global change rating scale in Alzheimer's disease
-
Knopman D.S., Knapp M.J., Gracon S.I., Davis C.S. The Clinician Interview-Based Impression (CIBI). a clinician's global change rating scale in Alzheimer's disease Neurology. 44:1994;2315-2321.
-
(1994)
Neurology
, vol.44
, pp. 2315-2321
-
-
Knopman, D.S.1
Knapp, M.J.2
Gracon, S.I.3
Davis, C.S.4
-
24
-
-
17944382037
-
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
-
Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D.et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
-
(2001)
Science
, vol.293
, pp. 1487-1491
-
-
Lewis, J.1
Dickson, D.W.2
Lin, W.L.3
Chisholm, L.4
Corral, A.5
Jones, G.6
Yen, S.H.7
Sahara, N.8
Skipper, L.9
Yager, D.10
-
25
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology. 34:1984;939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
26
-
-
84984755327
-
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
-
Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D.et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
-
(2000)
Nature
, vol.408
, pp. 982-985
-
-
Morgan, D.1
Diamond, D.M.2
Gottschall, P.E.3
Ugen, K.E.4
Dickey, C.5
Hardy, J.6
Duff, K.7
Jantzen, P.8
DiCarlo, G.9
Wilcock, D.10
-
27
-
-
0027425211
-
The Clinical Dementia Rating (CDR): Current version and scoring rules
-
Morris J.C. The Clinical Dementia Rating (CDR). current version and scoring rules Neurology. 43:1993;2412-2414.
-
(1993)
Neurology
, vol.43
, pp. 2412-2414
-
-
Morris, J.C.1
-
28
-
-
0024453856
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
-
Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1989;1159-1165.
-
(1989)
Neurology
, vol.39
, pp. 1159-1165
-
-
Morris, J.C.1
Heyman, A.2
Mohs, R.C.3
Hughes, J.P.4
Van Belle, G.5
Fillenbaum, G.6
Mellits, E.D.7
Clark, C.8
-
29
-
-
0027749448
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of propable Alzheimer's disease
-
Morris J.C., Edland S., Clark C., Galasko D., Koss E., Mohs R., van Belle G., Fillenbaum G., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of propable Alzheimer's disease. Neurology. 43:1993;2457-2465.
-
(1993)
Neurology
, vol.43
, pp. 2457-2465
-
-
Morris, J.C.1
Edland, S.2
Clark, C.3
Galasko, D.4
Koss, E.5
Mohs, R.6
Van Belle, G.7
Fillenbaum, G.8
Heyman, A.9
-
30
-
-
0038117796
-
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
-
Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 283:2000;1571-1577.
-
(2000)
JAMA
, vol.283
, pp. 1571-1577
-
-
Naslund, J.1
Haroutunian, V.2
Mohs, R.3
Davis, K.L.4
Davies, P.5
Greengard, P.6
Buxbaum, J.D.7
-
31
-
-
0030681215
-
Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease
-
The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 18:1997;S1-S2.
-
(1997)
Neurobiol. Aging
, vol.18
-
-
-
32
-
-
0037393454
-
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: A case report
-
Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide. a case report Nat. Med. 9:2003;448-452.
-
(2003)
Nat. Med.
, vol.9
, pp. 448-452
-
-
Nicoll, J.A.1
Wilkinson, D.2
Holmes, C.3
Steart, P.4
Markham, H.5
Weller, R.O.6
-
33
-
-
10744230547
-
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
-
in press
-
Orgogozo J.-M., Gilman S., Dartigues J.-F., Laurent B., Puel M., Kirby L.C., Jouanny P., Dubois B., Eisner L., Flitman S.et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology. in press:2003.
-
(2003)
Neurology
-
-
Orgogozo, J.-M.1
Gilman, S.2
Dartigues, J.-F.3
Laurent, B.4
Puel, M.5
Kirby, L.C.6
Jouanny, P.7
Dubois, B.8
Eisner, L.9
Flitman, S.10
-
35
-
-
0036780877
-
Amyloid-β immunotherapy for Alzheimer's disease: The end of the beginning
-
Schenk D. Amyloid-β immunotherapy for Alzheimer's disease. the end of the beginning Nat. Rev. Neurosci. 3:2002;824-828.
-
(2002)
Nat. Rev. Neurosci.
, vol.3
, pp. 824-828
-
-
Schenk, D.1
-
36
-
-
0033536163
-
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
-
Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K.et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
-
(1999)
Nature
, vol.400
, pp. 173-177
-
-
Schenk, D.1
Barbour, R.2
Dunn, W.3
Gordon, G.4
Grajeda, H.5
Guido, T.6
Hu, K.7
Huang, J.8
Johnson-Wood, K.9
Khan, K.10
-
37
-
-
0035066332
-
Alzheimer's disease: Genes, proteins, and therapy
-
Selkoe D.J. Alzheimer's disease. genes, proteins, and therapy Physiol. Rev. 81:2001;741-766.
-
(2001)
Physiol. Rev.
, vol.81
, pp. 741-766
-
-
Selkoe, D.J.1
-
38
-
-
0036855661
-
Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease
-
Selkoe D.J. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J. Clin. Invest. 110:2002;1375-1381.
-
(2002)
J. Clin. Invest.
, vol.110
, pp. 1375-1381
-
-
Selkoe, D.J.1
-
40
-
-
0036548070
-
γ-secretase, notch, Aβ and Alzheimer's disease: Where do the presenilins fit in?
-
Sisodia S.S., St. George-Hyslop P.H. γ-secretase, notch, Aβ and Alzheimer's disease. where do the presenilins fit in? Nat. Rev. Neurosci. 3:2002;281-290.
-
(2002)
Nat. Rev. Neurosci.
, vol.3
, pp. 281-290
-
-
Sisodia, S.S.1
St. George-Hyslop, P.H.2
-
41
-
-
0034568802
-
Intramembraneous proteolysis by presenilins
-
Steiner H., Haass C. Intramembraneous proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 1:2000;217-224.
-
(2000)
Nat. Rev. Mol. Cell Biol.
, vol.1
, pp. 217-224
-
-
Steiner, H.1
Haass, C.2
-
42
-
-
0035477333
-
The cell biology of Alzheimer's disease: Uncovering the secrets of secretases
-
Walter J., Kaether C., Steiner H., Haass C. The cell biology of Alzheimer's disease. uncovering the secrets of secretases Curr. Opin. Neurobiol. 11:2001;585-590.
-
(2001)
Curr. Opin. Neurobiol.
, vol.11
, pp. 585-590
-
-
Walter, J.1
Kaether, C.2
Steiner, H.3
Haass, C.4
-
44
-
-
0037180823
-
Inflammation and therapeutic vaccination in CNS diseases
-
Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature. 420:2002;879-884.
-
(2002)
Nature
, vol.420
, pp. 879-884
-
-
Weiner, H.L.1
Selkoe, D.J.2
|